Manapad, Naila .
HRN: 17-33-73 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/19/2026
CO-AMOXICLAV 625MG (TAB)
07/19/2026
07/25/2026
ORAL
Oral
BID
PROM; Thinly MSAF
Checking Final Appropriateness
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes